Literature DB >> 7085076

Antigenic analysis of Giardia lamblia from Afghanistan, Puerto Rico, Ecuador, and Oregon.

P D Smith, F D Gillin, N A Kaushal, T E Nash.   

Abstract

The trophozoite antigens of Giardia lamblia to which host humoral and cellular immune responses are directed have not been identified. Therefore, we initiated studies to characterize these antigens in strains of G. lamblia from Afghanistan, Oregon, Ecuador, and Puerto Rico. By polyacrylamide gel electrophoresis, the electrophoretic mobility patterns of proteins of the four strains were similar; molecular weights of protein bands ranged between 12,000 and 140,000. The antigens which reacted with rabbit and anti-G. lamblia antisera by immunoelectrophoresis were also similar for the four strains. However, comparison by crossed immunoelectrophoresis showed the Oregon strain, which has been the longest in culture, lacked a set of anodic antigens and the single neutral antigen which were present in the other three strains. In addition, other minor antigen differences between the strains were detected by this technique. When we employed trophozoites from each strain as antigen in an enzyme-linked immunosorbent assay against 10 human antisera of various liters, we also detected some differences between the strains. Although polyacrylamide gel electrophoresis and immunoelectrophoresis revealed gross similarity among G. lamblia from widely differing geographic locations, subtle differences detected by crossed electrophoresis and enzyme-linked immunosorbent assay suggest the existence of potentially important antigenic differences among these strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085076      PMCID: PMC351289          DOI: 10.1128/iai.36.2.714-719.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules.

Authors:  R C RENDTORFF
Journal:  Am J Hyg       Date:  1954-03

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

3.  Giardiasis: a common cause of prolonged diarrhoea in adults.

Authors:  T Heap
Journal:  Med J Aust       Date:  1974-10-19       Impact factor: 7.738

4.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

5.  Surgical treatment of intractable morbid obesity.

Authors:  B R Meyerowitz
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Epidemic giardiasis at a ski resort.

Authors:  G T Moore; W M Cross; D McGuire; C S Mollohan; N N Gleason; G R Healy; L H Newton
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

8.  An immunofluorescence test to detect serum antibodies to Giardia lamblia.

Authors:  G S Visvesvara; P D Smith; G R Healy; W R Brown
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

9.  Giardiasis in Colorado: an epidemiologic study.

Authors:  R A Wright; H C Spencer; R E Brodsky; T M Vernon
Journal:  Am J Epidemiol       Date:  1977-04       Impact factor: 4.897

10.  Two Plasmodium knowlesi-specific antigens on the surface of schizont-infected Rhesus monkey erythrocytes induce antibody production in immune hosts.

Authors:  R Schmidt-Ullrich; D F Wallach; J Lightholder
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  An atypical proprotein convertase in Giardia lamblia differentiation.

Authors:  B J Davids; M A Gilbert; Q Liu; D S Reiner; A J Smith; T Lauwaet; C Lee; A G McArthur; F D Gillin
Journal:  Mol Biochem Parasitol       Date:  2010-11-12       Impact factor: 1.759

3.  Identification of Conserved Candidate Vaccine Antigens in the Surface Proteome of Giardia lamblia.

Authors:  Barbara J Davids; Ching M Liu; Elaine M Hanson; Christine H Y Le; Jonathan Ang; Kurt Hanevik; Marvin Fischer; Matej Radunovic; Nina Langeland; Marcela Ferella; Staffan G Svärd; Majid Ghassemian; Yukiko Miyamoto; Lars Eckmann
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

4.  Isolation of two Giardia lamblia (WB strain) clones with distinct surface protein and antigenic profiles and differing infectivity and virulence.

Authors:  I A Udezulu; G S Visvesvara; D M Moss; G J Leitch
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 5.  Immunopathology of giardiasis.

Authors:  M J Farthing
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Sequence map of the 3-Mb Giardia duodenalis assemblage A chromosome.

Authors:  Jacqueline A Upcroft; Kenia G Krauer; Anita G Burgess; Linda A Dunn; Nanhua Chen; Peter Upcroft
Journal:  Chromosome Res       Date:  2009-10-16       Impact factor: 5.239

7.  Identification and characterization of a major surface antigen of Giardia lamblia.

Authors:  D A Einfeld; H H Stibbs
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Tubulin and high-molecular-weight polypeptides as Giardia lamblia antigens.

Authors:  B E Torian; R C Barnes; R S Stephens; H H Stibbs
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

9.  Antigenic variation of Giardia lamblia in vivo.

Authors:  A Aggarwal; T E Nash
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

10.  Comparison of Giardia isolates from different laboratories by isoenzyme analysis and recombinant DNA probes.

Authors:  W L Homan; F H van Enckevort; L Limper; G J van Eys; G J Schoone; W Kasprzak; A C Majewska; F van Knapen
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.